Last updated on October 2018

A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)

Brief description of study

The main purpose of this study is to evaluate the safety and efficacy of tadalafil in pediatric participants with pulmonary arterial hypertension. Participants will receive study treatment for 6 months in the double-blind period (Period 1), and then will be eligible to enroll into an open-label 2 year extension period (Period 2) during which participants will receive tadalafil.

Clinical Study Identifier: NCT01824290

Contact Investigators or Research Sites near you

Start Over

Masaru Miura

Tokyo Metropolitan Children's Medical Center
Fuchu, Japan
  Connect »

Hiroshi Ono

National Center For Child Health And Development
Setagaya-ku, Japan
  Connect »